SCHEMBL8307664

SCHEMBL8307664

ON=Cc1ccccc1CCOC1CCCCO1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.47
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KCNA5 P22460 3/20 0.35
SCN5A Q14524 3/20 0.35
HPGD P15428 3/20 0.34
ALDH1A1 P00352 2/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8306780 0.82 KDM4C (0.47) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8304469 0.81 KDM4C (0.42) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL10679113 0.79 KDM4C (0.53) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL8760063 0.79 MEN1 (0.34) KDM4CMEN1KMT2ANPC1RAB9A
SCHEMBL8309988 0.78 KDM4C (0.43) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL7690214 0.77 KDM4C (0.53) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL772902 0.77 KDM4C (0.53) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL29996581 0.77 MEN1 (0.46) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL772517 0.76 KDM4C (0.50) KDM4CMEN1KMT2AL3MBTL1NPC1
SCHEMBL13285758 0.76 KDM4C (0.50) KDM4CMEN1KMT2AL3MBTL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
US-5780490-A A O-(2,4-OXA(OR THIA)ZOLIDINYL)PHENYLOXY(OR THIO OR AMINO) ALKYLOXIME; ALDOSE REDUCTASE INHIBITORS; ANTIDIABETIC AND -HYPOGLYCEMIC AGENTS; LIVER, SKIN AND UROGENITAL DISORDERS SANKYO COMPANY, LIMITED (JP) 1998-07-14 US disclosed
US-5703096-A ANTIDIABETIC AGENTS; ALDOSE REDUCTASE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1997-12-30 US disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed